Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease.

× No keyword cloud information.

5 in total

1. Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.

Authors: K Kannari; H Yamato; H Shen; M Tomiyama; T Suda; M Matsunaga
Journal: J Neurochem Date: 2001-03 Impact factor: 5.372

2. Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).

Authors: C Warren Olanow; Philippe Damier; Christopher G Goetz; Thomas Mueller; John Nutt; Olivier Rascol; Alexandru Serbanescu; Frieda Deckers; Hermann Russ
Journal: Clin Neuropharmacol Date: 2004 Mar-Apr Impact factor: 1.592

3. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.

Authors: Maurits E L Arbouw; Kris L L Movig; Cees Neef; Henk-Jan Guchelaar; Toine C G Egberts
Journal: Eur J Clin Pharmacol Date: 2007-01-03 Impact factor: 2.953

4. A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson's disease.

Authors: Masahiko Tomiyama; Tamaki Kimura; Tetsuya Maeda; Kazuya Kannari; Muneo Matsunaga; Masayuki Baba
Journal: Neurosci Res Date: 2005-04-13 Impact factor: 3.304

5. Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors.

Authors: Petros N Karamanakos; Periklis Pappas; Marios Marselos
Journal: Behav Brain Res Date: 2004-01-05 Impact factor: 3.332

5 in total